|
1. BIOLOGIE
|
|
|
|
|
2.6 ETIOLOGIE - ENVIRONNEMENT
|
|
|
|
|
3.2 PRÉVENTION - OBÉSITÉ
|
|
|
|
4. DÉPISTAGE, DIAGNOSTIC ET PRONOSTIC
|
|
|
|
4.12 BIOPSIES LIQUIDES
|
|
|
|
|
4.2 DÉP., DIAG. & PRONO. - GÉNOME
|
|
|
I Had Lynch Syndrome For 30 Hours [Forbes]
|
|
|
|
|
|
I learned that, even as a genetic counselor who specializes in this area, it is almost impossible not to panic and consider the worst. This experience convinced me that genetic testing companies should be required to make their data available for public review so that such errors are more likely to be spotted.
|
|
|
|
|
|
|
5. TRAITEMENTS
|
|
|
|
5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES
|
|
|
|
5.2 PHARMA
|
|
|
|
|
5.5 ASCO
|
|
|
ASCO Genitourinary Cancers Symposium 2019 Preview [OBR]
|
|
|
|
|
|
ASCO experts singled out three abstracts to be presented at the meeting as of special interest: two on prostate cancer and one on kidney cancer. As would be expected, these three abstracts are just the tip of the iceberg among many important studies to be discussed at the 3-day meeting.
|
|
|
|
|
|
|
6.11 PATIENTS
|
|
|
|
6.4 MÉDICO-ÉCO
|
|
|
|
6.6 PUBLICATIONS
|
|
|
Can Big Science Be Too Big? [NY Times]
|
|
|
|
|
|
The new study suggests that a different kind of funding approach may be needed, one that takes more risk and spends the time and money to support promising individuals and small groups, Dr. Evans said.
|
|
|
|
|
|
|